Marché mondial de l’imagerie vasculaire – Tendances et prévisions de l’industrie jusqu’en 2031

Analyse et taille du marché de l'imagerie vasculaire

Le marché de l'imagerie vasculaire progresse grâce à des technologies de pointe telles que l'imagerie 3D et 4D, améliorant la précision diagnostique dans la détection des maladies vasculaires. Les méthodes les plus récentes comprennent l'échographie avec contraste et l'angiographie par soustraction numérique, optimisant la clarté de l'image. La croissance est alimentée par l'incidence croissante des troubles cardiovasculaires et les innovations technologiques, qui stimulent la demande de solutions d'imagerie non invasives et précises.                               

Français La taille du marché mondial de l'imagerie vasculaire était évaluée à 6,27 milliards USD en 2023 et devrait atteindre 9,51 milliards USD d'ici 2031, avec un TCAC de 5,35 % au cours de la période de prévision 2024 à 2031. En plus des informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également une analyse approfondie des experts, l'épidémiologie des patients, l'analyse du pipeline, l'analyse des prix et le cadre réglementaire.

Portée du rapport et segmentation du marché

Market Definition

Vascular imaging is a medical technique used to visualize blood vessels within the body. It employs various imaging modalities such as ultrasound, CT angiography, MRI angiography, and X-ray angiography to diagnose and assess conditions affecting the vascular system, including aneurysms, stenosis, and thrombosis. These non-invasive or minimally invasive methods provide detailed images essential for planning interventions and monitoring vascular health.            

Vascular Imaging Market Dynamics

Drivers

• Rising Incidence of Chronic Diseases

The rising incidence of chronic diseases such as diabetes and hypertension significantly increases the risk of vascular disorders. This heightened risk underscores the critical need for regular vascular imaging to detect and manage these conditions early. For instance, diabetic patients often develop peripheral artery disease, necessitating precise imaging for timely intervention. This demand for early detection and effective management drives the growth of the vascular imaging market globally.

• Growing Demand for Non-Invasive Diagnostic Techniques

The growing preference for non-invasive or minimally invasive diagnostic procedures is driving the adoption of vascular imaging technologies. Patients favor these methods due to reduced discomfort and shorter recovery times compared to traditional invasive procedures. For instance, techniques such as ultrasound and CT angiography offer detailed vascular images without the need for surgical intervention, making them increasingly popular choices among healthcare providers and patients, thereby expanding the vascular imaging market.

Opportunities

• Supportive Government Initiatives and Funding

Supportive government initiatives and funding for medical imaging technologies create significant opportunities in the market by fostering innovation and affordability. For instance, programs such as the National Institutes of Health (NIH) in the United States allocate substantial funding to advance vascular imaging research. This financial support not only accelerates technological advancements but also enhances accessibility to cutting-edge imaging solutions, thereby driving market growth and improving patient care outcomes globally.

• Integration of Artificial Intelligence (AI) and Machine Learning

Integration of Artificial Intelligence (AI) and Machine Learning in vascular imaging creates significant market opportunities by enhancing diagnostic capabilities. AI algorithms analyze complex vascular images swiftly and accurately, aiding in early detection of conditions such as arterial blockages or aneurysms. For instance, AI-powered software such as Viz.ai helps detect and prioritize large vessel occlusions in stroke patients, improving treatment outcomes. Such advancements attract healthcare providers seeking efficient and precise diagnostic solutions, driving adoption and market growth.

Restraints/Challenges

• High Cost of Equipment and Maintenance

The high cost of vascular imaging equipment, such as MRI and CT scanners, poses a significant barrier for healthcare facilities, especially in budget-constrained regions. This financial burden discourages investments in advanced technology upgrades, limiting access to improved diagnostic capabilities. As a result, healthcare providers may struggle to meet patient demand for sophisticated vascular imaging services, perpetuating disparities in healthcare access and quality. 

• Patient Safety Concerns

Patient safety concerns, such as those related to contrast agents and ionizing radiation used in certain vascular imaging techniques, pose significant challenges for the market. The potential for side effects and long-term health risks creates hesitation among both healthcare providers and patients, impacting adoption rates. Balancing diagnostic efficacy with safety concerns remains a critical hurdle for manufacturers and healthcare facilities asuch as in the vascular imaging sector.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In October 2023, Abbott introduced Ultreon 1.0 Software in India, merging optical coherence tomography (OCT) with artificial intelligence (AI). This innovative software aims to enhance precision in medical imaging, particularly for cardiovascular procedures
• In November 2023, BD launched SiteRite 9, an advanced ultrasound system designed to improve the placement of vascular access devices. This system promises increased accuracy and efficiency in clinical settings
• In August 2023, GE Healthcare unveiled Vscan Air SL, a handheld, wireless ultrasound imaging solution. Primarily used for rapid assessment in vascular and cardiac care, its release is poised to bolster healthcare efficiency and patient outcomes globally

Vascular Imaging Market Scope

The market is segmented on the basis of technique, procedure, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Technique

• Magnetic Resonance Imaging
• Ultrasound
• Computed Tomography
• Nuclear Imaging
• X-Ray

 Procedure

• Coronary Angiography
• Peripheral Angiography
• Neurovascular Angiography
• Vascular Ultrasound Procedures
• Micro angiography
• Others

 Application

• Diagnostic Applications
• Therapeutic Applications

 End User

• Hospitals
• Diagnostic Imaging Centres
• Others

Vascular Imaging Market Regional Analysis/Insights

The market is analysed and market size insights and trends are provided by country, technique, procedure, application and end user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to dominate the vascular imaging market, driven by major players and streamlined repayment regulations. The region's increasing incidence of stroke will further fuel market growth during the forecast period.

Asia-Pacific is projected to observe significant growth in the vascular imaging market, driven by increasing incidences of cardiovascular disorders. This trend underscores heightened demand for advanced diagnostic technologies across the region. Rapid urbanization, lifestyle changes, and improving healthcare infrastructure further contribute to this anticipated market expansion in Asia-Pacific.

La section pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements de réglementation sur le marché national qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que l'analyse de la chaîne de valeur en aval et en amont, les tendances techniques et l'analyse des cinq forces de Porter, les études de cas sont quelques-uns des indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques mondiales et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des tarifs nationaux et les routes commerciales sont pris en compte tout en fournissant une analyse prévisionnelle des données nationales.   

Croissance des infrastructures de santé Base installée et pénétration des nouvelles technologies

Le marché vous fournit également une analyse détaillée du marché pour chaque pays, la croissance des dépenses de santé pour les biens d'équipement, la base installée de différents types de produits pour le marché, l'impact de la technologie à l'aide de courbes de vie et les changements dans les scénarios réglementaires des soins de santé et leur impact sur le marché. Les données sont disponibles pour la période historique 2016-2021.

Analyse du paysage concurrentiel et des parts de marché de l'imagerie vasculaire

Le paysage concurrentiel du marché fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises par rapport au marché.

Certains des principaux acteurs opérant sur le marché sont :

• Siemens Healthcare Private Limited (Allemagne)
• GE HealthCare (États-Unis)
• Centre médical suédois (États-Unis)
• Hôpital Brigham and Women's (États-Unis)
•  Hitachi Healthcare Americas (Japon)
•  Koninklijke Philips NV (Pays-Bas)
• Société Shimadzu (Japon)
• Samsung Medison Co., Ltd. (Corée du Sud)
• Abbott (États-Unis)
• FUJIFILM Corporation (Japon)
• Esaote SPA (Italie)
•  Carestream Health (États-Unis)
• TERUMO CORPORATION (Japon)
• Konica Minolta, Inc. (Japon)
• Pie Medical Imaging BV (Pays-Bas)
•  ALPINION MEDICAL SYSTEMS Co., Ltd. (Corée du Sud)
•  CorVascular Diagnostics, LLC (États-Unis)

SKU-9096